Stay updated on FT538 with Daratumumab in AML Clinical Trial

Sign up to get notified when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FT538 with Daratumumab in AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new revision tag 'Revision: v3.4.1' appears, replacing the previous 'Revision: v3.4.0' in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:26:50.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    UI updates on the record history page add a glossary toggle, emphasize changes with green/red highlights, and show revision/version information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1.0%
    Check dated 2026-01-28T21:16:38.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A new page revision was added to the history: v3.3.4, replacing the prior revision v3.3.3. To avoid alerts for small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:59:27.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3. The HHS Vulnerability Disclosure and Revision: v3.3.2 links were removed.
    Difference
    0.2%
    Check dated 2025-12-23T21:45:08.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2 to the record history and removed Revision: v3.2.0. This is an administrative update to the page's versioning and does not alter study data or page content.
    Difference
    0.1%
    Check dated 2025-11-25T10:27:28.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Deleted a government funding notice about site operations. The core study history information remains unaffected.
    Difference
    0.7%
    Check dated 2025-11-18T06:50:05.000Z thumbnail image

Stay in the know with updates to FT538 with Daratumumab in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.